Medwise.ai vs OpenEvidence
Two clinical search products built for different accountability structures. Medwise is built for a national health service, with its corpus assembled and governed against that institution's own guidance, which matters because clinicians there are judged against national standards rather than against the primary literature. OpenEvidence answers from current published evidence through partnerships with major journals, is free to verified clinicians and carries the deepest independent evaluation literature in this category. The divergence between national guidance and the latest literature is real and neither vendor dwells on it. Inside that health service, answering from the guidance you are accountable to is the safer position. Outside it, OpenEvidence has far more external scrutiny behind it, and its advertising funded model is the thing to weigh.
- It is built for one national health service, with the corpus assembled and governed to that institution's requirements rather than to a general market.
- Its platform terms carry a published statement about the limits of the answers that is unlike anything else in this category.
- For an organisation inside that health service, a product configured to its own guidance is closer to the standard clinicians are held to than a global corpus.
- The independent literature is the deepest in this category, with a systematic review identifying eleven studies evaluating the product across two years.
- Named partnerships with major journals and a systematic review publisher supply current primary literature rather than a national guidance set.
- It is free to verified clinicians with native mobile applications and enterprise record system embedding at named health systems.
Side by Side
| Axis | M Medwise.ai |
O OpenEvidence |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
These are built for different evidentiary cultures and the comparison should not be run on breadth: one answers from national guidance a clinician is accountable to, the other from the primary literature, and those diverge more often than either vendor acknowledges.
OpenEvidence is funded by pharmaceutical and device advertising displayed alongside clinical answers, governed by a published policy that should be read before deployment in any setting where that relationship would be unacceptable. Medwise publishes no security certification, no verified record system integration and a commercial account that has been inconsistent across time. Neither publishes an accuracy figure.